GSK invests $300,000 to help launch the Pharmacy Innovation in Immunization Research Collaborative (PIIRC) at the University of Waterloo School of Pharmacy
Summary
GSK is investing $300,000 to help launch PIIRC, a new national research collaborative at the University of Waterloo School of Pharmacy. The initiative will study how pharmacies can improve vaccine access, delivery, education, and evidence generation across Canada. It will also explore digital health tools, data-driven outreach, and policy support for broader immunization services. The collaboration brings together researchers, policymakers, healthcare stakeholders, and industry partners to expand the role of pharmacies in public health.
Funding
Amount
$300.0K
Total raised
Date
June 6, 2025
Announcement date
Investors
GlaxoSmithKline
Lead investors
Company
uwaterloo.ca
Funded company
Classifications
industries
No industries detected
applications
No applications detected
AskAI Classifications
Labels
No AI classifications detected